Publications by authors named "Patrick Swann"

Claim this Profile
Q
Quantitation and pharmacokinetic modeling of therapeutic antibody quality attributes in human studies.
Yinyin Li, Michael Monine, Yu Huang, Patrick Swann, Ivan Nestorov

MAbs· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing.
Mo Jiang, Kristen A Severson, John Christopher Love, Helena Madden, Patrick Swann

Biotechnol Bioeng· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A View on the Importance of "Multi-Attribute Method" for Measuring Purity of Biopharmaceuticals and Improving Overall Control Strategy.
Richard S Rogers, Michael Abernathy, Douglas D Richardson, Jason C Rouse, Justin B Sperry, Patrick Swann

AAPS J· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of risk assessments in viral safety: an FDA perspective.
Lixin Xu, Sang Bong Lee, Chana Fuchs, Kenneth C Hyams, Kurt Brorson, Patrick Swann

PDA J Pharm Sci Technol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory considerations for development of bioanalytical assays for biotechnology products.
Patrick G Swann, Marjorie A Shapiro

Bioanalysis· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality.
John F Carpenter, Theodore W Randolph, Wim Jiskoot, Daan J A Crommelin, C Russell Middaugh, Patrick G Swann

J Pharm Sci· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for the development of therapeutic monoclonal antibodies.
Patrick G Swann, Mate Tolnay, Subramanian Muthukkumar, Marjorie A Shapiro, Barbara L Rellahan

Curr Opin Immunol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.
C T Viswanathan, Surendra Bansal, Brian Booth, Anthony J DeStefano, Mark J Rose, Patrick G Swann

Pharm Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and future issues in the manufacturing and development of monoclonal antibodies.
Steven Kozlowski, Patrick Swann

Adv Drug Deliv Rev· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of cell culture process changes on endogenous retrovirus expression.
Kurt Brorson, Christina De Wit, Elizabeth Hamilton, Mehnaz Mustafa, Patrick G Swann

Biotechnol Bioeng· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a quantitative product-enhanced reverse transcriptase assay to monitor retrovirus in mAb cell-culture.
Kurt Brorson, Yuan Xu, Patrick G Swann, Elizabeth Hamilton, Mehnaz Mustafa

Biologicals· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis